Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States: 1993-2006

PACE - Pacing and Clinical Electrophysiology

Volumn 33, Issue 6, 2010, Pages 705-711

  Kurtz, Steven M ^a   Ochoa, Jorge A ^a,b   Lau, Edmund ^a   Shkolnikov, Yakov ^a   Pavri, Behzad B ^c   Frisch, Daniel ^c   Greenspon, Arnold J ^c  

^a DREXEL UNIVERSITY   (United States)

^b University of Washington   (United States)

^c THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Epidemiology; Implantable cardioverter defibrillator ICD; Pacemaker; Utilization

Indexed keywords

ARTICLE; COMORBIDITY; DEFIBRILLATOR; DEVICE REMOVAL; FEMALE; HUMAN; IMPLANTATION; MALE; MORTALITY; PACEMAKER; TREND STUDY; UNITED STATES; AGED; ARTIFICIAL HEART PACEMAKER; BRADYCARDIA; ECONOMICS; EPIDEMIOLOGY; HEART FAILURE; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MIDDLE AGED; PROSTHESIS FAILURE; TREATMENT OUTCOME; TRENDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BRADYCARDIA; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PROSTHESIS FAILURE; TREATMENT OUTCOME; UNITED STATES;

EID: 77953180116     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2009.02670.x     Document Type: Article

References (29)

1. Goldberger Z, Lampert R. Implantable cardioverter defibrillators: Expanding indications and technologies. JAMA 2006 295:809-818.
2. Naccarelli GV. Implantable cardioverter defibrillators: Expanding indications. Curr Opin Cardiol 2004 19:317-322.
3. Raj SR, Sheldon RS. The implantable cardioverter defibrillator: Does everybody need one? Prog Cardiovasc Dis 2001 44:169-194.
4. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996 335:1933-1940.
5. Moss AJ, Fadl Y, Zareba W, Cannom DS, Hall WJ. Survival benefit with an implanted defibrillator in relation to mortality risk in chronic coronary heart disease. Am J Cardiol 2001 88:516-520.
6. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004 350:2151-2158.
7. Passman R, Kadish A. Sudden death prevention with implantable devices. Circulation 2007 116:561-571.
8. Gregoratos G. Indications and recommendations for pacemaker therapy. Am Fam Physician 2005 71:1563-1570.
9. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004 350:2140-2150.
10. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005 352:1539-1549. (Pubitemid 40517094)
11. Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H, Zareba W, et al. Risk stratification for primary implantation of a cardioverter defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 2008 51:288-296.
12. Parkash R, Stevenson WG, Epstein LM, Maisel WH. Predicting early mortality after implantable defibrillator implantation: A clinical risk score for optimal patient selection. Am Heart J 2006 151:397-403.
13. DiMarco JP. Implantable cardioverter defibrillators. N Engl J Med 2003 349:1836-1847.
14. Lamas GA, Knight JD, Sweeney MO, Mianulli M, Jorapur V, Khalighi K, Cook JR, et al. Impact of rate-modulated pacing on quality of life and exercise capacity - evidence from the Advanced Elements of Pacing Randomized Controlled Trial (ADEPT). Heart Rhythm 2007 4:1125-1132.
15. Zwanziger J, Hall WJ, Dick AW, Zhao H, Mushlin AI, Hahn RM, Wang H, et al. The cost effectiveness of implantable cardioverter defibrillators: Results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol 2006 47:2310-2318.
16. Mond HG, Irwin M, Ector H, Proclemer A. The world survey of cardiac pacing and cardioverter defibrillators: Calendar year 2005 an International Cardiac Pacing and Electrophysiology Society (ICPES) project. Pacing Clin Electrophysiol 2008 31:1202-1212.
17. Proclemer A, Ghidina M, Cicuttini G, Gregori D, Fioretti PM. Impact of the main implantable cardioverter defibrillator trials for primary and secondary prevention in Italy: A survey of the national activity during the years 2001-2004. Pacing Clin Electrophysiol 2006 29:S20-S28.
18. Proclemer A, Ghidina M, Gregori D, Facchin D, Rebellato L, Fioretti P, Brignole M. Impact of the main implantable cardioverter defibrillator trials in clinical practice: Data from the Italian ICD Registry for the years 2005-07. Europace 2009 11:465-475.
19. Hammill SC, Stevenson LW, Kadish AH, Kremers MS, Heidenreich P, Lindsay BD, Mirro MJ, et al. Review of the registry's first year, data collected, and future plans. Heart Rhythm 2007 4:1260-1263.
20. Comparative Analysis of HCUP and NHDS Inpatient Discharge Data [Agency for Health Care Policy and Research], 1996. Available from:http://www.ahrq.gov/ data/hcup/nhds/niscomp.htm. Accessed June 6, 2009.
21. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987 40:373-383.
22. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992 45:613-619.
23. Ong KL, Kurtz SM, Lau E, Bozic KJ, Berry DJ, Parvizi J. Prosthetic joint infection risk after total hip arthroplasty in the medicare population. J Arthroplasty 2009 24 (6 Suppl):105-109.
24. The antiarrhythmics versus implantable defibrillators (avid) investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997 337:1576-1583.
25. Summary of coverage for implantable cardioverter defibrillators (ICDs) as of January 27, 2005 [Centers for Medicare & Medicaid Services (CMS)], 2005. Available from:http://www.cms.hhs.gov/coverage/download/id148a.pdf. Accessed June 25, 2009.
26. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, et al. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices - summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Am Coll Cardiol 2002 40:1703-1719. (Pubitemid 35253652)
27. Morgan JM. The MADIT II and COMPANION studies: Will they affect uptake of device treatment? Heart 2004 90:243-245.
28. Gregoratos G, Cheitlin MD, Conill A, Epstein AE, Fellows C, Ferguson TB, Jr, Freedman RA, et al. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol 1998 31:1175-1209. (Pubitemid 28212525)
29. Coats AJ. MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials? Int J Cardiol 2002 82:1-5.